Botanical Name : Pueraria mirifica Family: Fabaceae Subfamily: Faboideae Genus: Pueraria Species: P. mirifica Kingdom: Plantae Order: Fabales
Common Name :Kwao Krua, Khao Krua Kao, or Kwao Kreu Kao (white root) and Kwao Krua Dang (red root Butea Superba),
Habitat :Pueraria mirifica is a native herb abundant in the jungles of the north Thailand and Burma.
The Pueraria mirifica plant is found only in Thailand. Even though there have been reports of findings of plants in the same family of “Pueraria” in Asian countries, these plant are of different species and possess different qualities from Pueraria mirifica. From the study, there are nine species [as many as thirteen have now been reported] of Pueraria in Thailand. This article discussing the efficacy and safety study of Pueraria mirifica refers only to Pueraria candollei var. mirifica from central part of the country. Pueraria mirifica is a climbing plant, usually grows in a mountainous area by tiding with trees. There are three small leaves on each branch and purple blooms on the top. The tubers on its root are round, and stay underground. When cut, white liquid like skim milk would come out. The Shape and size of Pueraria mirifica are diverse up to the environment in which it exists. Active ingredients are found at the roots from which extracts are made. CLICK & SEE THE PICTURES
Arimuttama was the old capital of the Pookham City of Myanmar. They had a sacred Buddhist precinct and one-day the sacred Buddhist precinct was broken down. The Buddhist monks found this ingredient that was inscribed on the palm leaf and placed it in the sacred Buddhist precinct.
To take the tuberous root of Pueraria with big leaves, pound and blend with cow’s milk. The benefits of this medicine is to support memory, talk big, and be able to remember three books of the astrology, make the skin smooth like six year old kid, live more than 1,000 years and parasite diseases are not able to be of trouble
There are 4 varieties of kwao krua that are considered beneficial and can be used for medicinal, food supplementary and cosmetic purposes. They are White Kwao Krua (Pueraria mirifica), Red Kwao Krua (Butea superba), Black Kwao Krua and Dull Grey Kwao Krua. Local communities in Thailand have used Pueraria mirifica for well over one hundred years, specifically for its supposed rejuvenating qualities
Pueraria mirifica, also known as ‘white kwao krua’, is a natural tuberous herbal root and contains high levels of natural phytoestrogens including miroestrol, deoxymiroestrol, daidzein, genistin, genistein, B-Sitosterol, stigmasterol, coumestrol, pueraria, campesterol, mirificoumestan, kwakhurin, and mirificine.
Some cosmetic products and herbal supplements claim various health benefits of the extracts of Pueraria mirifica including increasing appetite, enlarging breasts, improving hair growth, and other rejuvenating effects; however, there is no scientific evidence to support any these claims. The U.S. Federal Trade Commission has taken action against manufacturers who make such fraudulent claims
Preliminary data from a clinical trial conducted in Thailand to study the beneficial effect of Pueraria mirifica supplement have recently been obtained. Eight female subjects who were having menopausal symptoms received Pueraria mirifica in the form of capsule once daily at the dose of 200 mg for 4 months followed by the dose of 100 mg, for 8 months. Improvement of menopausal symptoms was observed in 5 out of 8 subjects throughout the study period. Physical examinations and biochemical studies revealed that all subjects were healthy. The dietary supplement dose of Pueraria mirifica recommended by the physician for its estrogenic effect in this case is 100 mg per day.
A series of studies involving breast cell lines and the activity of Pueraria mirifica in vitro have been performed by the Emory University School of Medicine in Atlanta, Georgia, USA, and the Department of Obstetrics and Gynecology, Phramongkutklao College of Medicine, Bangkok, Thailand. These studies have shown that Pueraria mirifica root extract (Smith Naturals Co Ltd., Bangkok) has potent anti-estrogenic properties against aggressive cell cancer lines in vitro, especially the proliferative estrogen receptor-positive (ER+) breast cancer lines (T47-D, MCF-7, and ZR-75-1) obtained from the MD Anderson Cancer Institute (Texas) and the National Cancer Institute (NCI) at the U.S. National Institutes of Health (NIH).
Tectorigenin, an isoflavone present in kudzu, demonstrated antiproliferative activity against human cancer (HL-60) cells. The proposed mechanisms are induction of differentiation in the cells and a reduction in the expression of Bcl-2, an antiapoptotic protein. In addition, isoflavones in Pueraria mirifica are thought to be involved in alleviating symptoms such as hot flashes and night sweats in perimenopausal women and affect cognitive function in postmenopausal women. The isoflavones present in kudzu root extract are also thought to suppress alcohol intake and alcohol withdrawal symptoms in mice although the mechanism is unclear. The anti-inflammatory property of kudzu is attributed to its ability to decrease Prostaglandin E2 and tumor necrosis factor (TNF)-alpha release, both of which are involved in inflammatory process. The flowers of Pueraria thunbergiana exhibit protective effects against ethanol-induced apoptosis in human neuroblastoma cells by inhibiting the expression of a protease, caspase-3 that is responsible for proteolytic cleavage of many proteins.
Herbal Breast Enlargement by Pueraria mirifica. In 90% of women, the phytoestrogen from Pueraria herbal will induce the increasing of the cell turgidity but not cell multiplication or proliferation.
The information presented herein is intended for educational purposes only. Individual results may vary, and before using any supplements, it is always advisable to consult with your own health care provider.
Definition:– Feeding problem of infancy or early childhood is characterized by the failure of an infant or child under six years of age to eat enough food to gain weight and grow normally over a period of one month or more. The disorder can also be characterized by the loss of a significant amount of weight over one month. Feeding disorder is similar to failure to thrive, except that no medical or physiological condition can explain the low food intake or lack of growth. CLICK & SEE THE PICTURES
Infants and children with a feeding disorder fail to grow adequately, or even lose weight with no underlying medical explanation. They do not eat enough energy or nutrients to support growth and may be irritable or apathetic. Factors that contribute to development of a feeding disorder include lack of nurturing, failure to read the child’s hunger and satiety cues accurately, poverty, or parental mental illness. Successful treatment involves dietary, behavioral, social, and psychological intervention by a multidisciplinary
Feeding problems are common throughout childhood and affect both boys and girls.
The kind of feeding problem may depend on the age of the child.
Some new mothers take a while to get the hang of breastfeeding and may worry they’re not producing sufficient milk or their baby isn’t satisfied. But as long as the baby is gaining weight at the normal rate, there’s no need for concern.
Occasionally, early feeding problems are due to anatomical difficulties (for example, a severe cleft palate or oesophageal atresia) or more general illness, but these are usually quickly identified.
Minor infections, such as a cold, can interrupt established feeding patterns, but rarely for long.
More serious conditions can interfere with the absorption of food and weight gain, including coeliac disease, cystic fibrosis, inflammatory bowel disease and food intolerance.
In toddlers and older children, emotional and social factors can cause feeding problems. Older children, especially girls, are more likely to develop eating disorders such as anorexia nervosa and bulimia.
The symptoms of feeding disorders can vary, but common symptoms include:
•Lack of appetite
•Crying before or after food
•Failing to gain weight normally
•Regurgitating or vomiting
Between 25% and 35% of normal children experience minor feeding problems. In infants born prematurely, 40% to 70% experience some type of feeding problem. For a child to be diagnosed with feeding disorder of infancy or early childhood, the disorder must be severe enough to affect growth for a significant period of time. Generally, growth failure is considered to be below the fifth percentile of weight and height.
Feeding disorder of infancy or early childhood is diagnosed if all four of the following criteria are present:
•Failure to eat adequately over one month or more, with resultant weight loss or failure to gain weight.
•Inadequate eating and lack of growth not explained by any general medical or physiological condition, such as gastrointestinal problems, nervous system abnormalities, or anatomical deformations.
•The feeding disorder cannot be better explained by lack of food or by another mental disorder, such as rumination disorder.
•The inadequate eating and weight loss or failure to gain weight occurs before the age of six years. If feeding behavior or weight gain improves when another person feeds and cares for the child, the existence of a true feeding disorder, rather than some underlying medical condition, is more likely.
Successful treatment of feeding disorders requires a multidisciplinary team approach to assess the child’s needs and to provide recommendations and education to improve feeding skills, behavior, and nutrient intake. The multidisciplinary team for treatment of feeding disorders in childhood usually includes physicians specializing in problems of the gastrointestinal tract or of the ear, nose, and throat; a dietitian, a psychologist , a speech pathologist, and an occupational therapist. Support from social workers and physicians in related areas of medicine is also helpful.
An initial evaluation should focus on feeding history, including detailed information on type and timing of food intake, feeding position, meal duration, energy and nutrient intake, and behavioral and parental factors that influence the feeding experience. Actual observation of a feeding session can give valuable insight into the cause of the feeding disorder and appropriate treatments. A medical examination should also be conducted to rule out any potential medical problems or physical causes of the feeding disorder.
After a thorough history is taken and assessment completed, dietary and behavioral therapy is started. The goal of diet therapy is to gradually increase energy and nutrient intake as tolerated by the child to allow for catch up growth. Depending on the diet history, energy and nutrient content of the diet may be kept lower initially to avoid vomiting and diarrhea. As the infant or child is able to tolerate more food, energy and nutrient intake is gradually increased over a period of one to two weeks, or more. Eventually, the diet should provide about 50% more than normal nutritional needs of infants or children of similar age and size.
Behavioral therapy can help the parent and child overcome conditioned feeding problems and food aversions. Parents must be educated to recognize their child’s hunger and satiety cues accurately and to promote a pleasant, positive feeding environment. Changing the texture of foods, the pace and timing of feedings, the position of the body, and even feeding utensils can help the child overcome aversions to eating. If poverty, abuse, or parental mental illness contribute to the feeding disorder, these issues must also be addressed.
If left untreated, infants and children with feeding disorders can have permanent physical, mental, and behavioral damage. However, most children with feeding disorders show significant improvements after treatment, particularly if the child and parent receive intensive nutritional, psychological, and social intervention.
Providing balanced, age-appropriate foods at regular intervals—for example, three meals and two or three snacks daily for toddlers—can help to establish healthy eating patterns. If a child is allowed to fill up on soft drinks, juice, chips, or other snacks prior to meals, appetite for other, more nutritious foods will decrease.
Positive infant and childhood feeding experiences require the child to communicate hunger and satiety effectively and the parent or caregiver to interpret these signals accurately. This set of events requires a nurturing environment and an attentive, caring adult. Efforts should be made to establish feeding as a positive, pleasant experience. Further, forcing a child to eat or punishing a child for not eating should be avoided.
Disclaimer: This information is not meant to be a substitute for professional medical advise or help. It is always best to consult with a Physician about serious health concerns. This information is in no way intended to diagnose or prescribe remedies.This is purely for educational purpose.
In another study, a total of 1,000 post-menopausal women were asked to take natural supplements that contained vitamin D and calcium. The researchers found that the participants had a much lower risk of being diagnosed with breast cancer, the news source reports.
While researchers across the country have found many benefits from a high intake of vitamin D, investigators conclude that further studies are necessary to rule out potential negative effects of the nutrient.
Nine out of 10 Americans are deficient in vitamin D… the sunshine vitamin. And surprisingly, even people that spend plenty of time in the sun can still lack this vital inflammation fighter.
This is dangerous because inflammation is a major cause of heart and brain attacks… high blood pressure… joint pain… bone loss… digestive problems… blood sugar imbalances and a host of other serious health problems.
But the good news is: You can quickly restore healthy levels of vitamin D with Advanced D3 Plus™ from Health Resources™ and even REVERSE many of your most dangerous health problems.
But you must have the RIGHT kind of natural vitamin D combined with the best quality ingredients for optimum bone, heart and brain health. To find out more, Click Here… :http://www.healthresources.net/p-142-advanced-d3-plus.aspx
The lymphatic system includes a network of thin tubes that branch, like blood vessels, into tissues throughout the body. Lymphatic vessels carry lymph, a colorless watery fluid that contains infection-fighting cells called lymphocytes. Along this network of vessels are groups of small, bean-shaped organs called lymph nodes. Clusters of lymph nodes are found in the underarms, groin, neck, chest, and abdomen.
Other parts of the lymphatic system are the spleen, thymus, tonsils, and bone marrow. Lymphatic tissue also is found in other parts of the body, including the stomach, intestines, and skin.
Non-Hodgkin’s lymphoma, also called non-Hodgkin lymphoma, is cancer that originates in your lymphatic system, the disease-fighting network spread throughout your body. In non-Hodgkin’s lymphoma, tumors develop from lymphocytes — a type of white blood cell.
Non-Hodgkin’s lymphoma is more common than the other general type of lymphoma — Hodgkin’s disease.
Many different subtypes of non-Hodgkin’s lymphoma exist. The most common non-Hodgkin’s lymphoma subtypes include diffuse large B-cell lymphoma and follicular lymphoma.
Within normal lymph nodes there are microscopic clusters (follicles) of specialized lymphocytes. In some malignant lymphomas, the lymphocytes arrange themselves in a similar pattern that is called follicular or nodular. Small cell and follicular lymphomas typically have a chronic course with an average survival of 6 to 12 years. In the more aggressive lymphomas, the normal appearance of the lymph node is lost by diffuse involvement of tumor cells, which are usually moderate-sized or large.
Hodgkin’s disease, the most common lymphoma, has special characteristics that distinguish it from the others. Often it is identified by the presence of a unique cell, called the Reed-Sternberg cell, in lymphatic tissue that has been surgically removed for biopsy.
Hodgkin’s disease tends to follow a more predictable pattern of spread, and its spread is generally more limited than that of the non-Hodgkin’s lymphomas. By contrast, the non-Hodgkin’s lymphomas are more likely to begin in extranodal sites (organs other than the lymph nodes, like the liver and bones).
There are about ten different types of Non-Hodgkin’s lymphoma. Some types spread more quickly than others. The type is determined by how the cells look under a microscope (histology). The histologies are grouped together, based on how quickly they spread, into low-grade, intermediate-grade, or high-grade lymphomas.
The most common symptom of non-Hodgkin’s lymphomas is a painless swelling in the lymph nodes of the neck, underarm, or groin. Other symptoms may include fevers, night sweats, tiredness, weight loss, itching, and reddened patches on the skin. Sometimes there is nausea, vomiting, or abdominal pain.
Symptoms of non-Hodgkin’s lymphoma may include:
*Swollen lymph nodes in your neck, armpit or groin
*Abdominal pain or swelling
*Chest pain, coughing or trouble breathing
As lymphomas progress, the body is less able to fight infection. These symptoms are not sure signs of cancer, however. They also may be caused by many common illnesses, such as the flu or other infections. But it is important to see a doctor if any of these symptoms lasts longer than 2 weeks.
The cause of most lymphoma is unknown. Some occur in individuals taking drugs to suppress their immune system.
Non-Hodgkin’s lymphoma occurs when your body produces too many abnormal lymphocytes — a type of white blood cell. Normally, lymphocytes go through a predictable life cycle. Old lymphocytes die, and your body creates new ones to replace them. In non-Hodgkin’s lymphoma, your lymphocytes don’t die, but continue to grow and divide. This oversupply of lymphocytes crowds into your lymph nodes, causing them to swell.
B cells and T cells
There are two types of lymphocytes, and non-Hodgkin’s lymphoma usually involves one or the other.
*B cells. B cells fight infection by producing antibodies that neutralize foreign invaders. Most non-Hodgkin’s lymphoma arises from B cells.
*T cells. T cells are involved in killing foreign invaders directly. Non-Hodgkin’s lymphoma occurs less often in T cells.
Whether your non-Hodgkin’s lymphoma arises from your B cells or T cells helps to determine your treatment options.
In most cases, people diagnosed with non-Hodgkin’s lymphoma don’t have any obvious risk factors, and many people who have risk factors for the disease never develop it. Some factors that may increase the risk of non-Hodgkin’s lymphoma include:
*Medications that suppress your immune system. If you’ve had an organ transplant, you’re more susceptible because immunosuppressive therapy has reduced your body’s ability to fight off new illnesses.
*Infection with certain viruses and bacteria. Certain viral and bacterial infections appear to increase the risk of non-Hodgkin’s lymphoma. Viruses linked to increased non-Hodgkin’s lymphoma risk include HIV, hepatitis C virus and Epstein-Barr virus. Bacteria linked to an increased risk of non-Hodgkin’s lymphoma include the ulcer-causing Helicobacter pylori.
*Chemicals. Certain chemicals, such as those used to kill insects and weeds, may increase your risk of developing non-Hodgkin’s lymphoma. More research is needed to understand the possible link between pesticides and the development of non-Hodgkin’s lymphoma.
*Older age. Non-Hodgkin’s lymphoma can occur at any age, but the risk increases with age. It’s most common in people in their 60s or older.
Tests and procedures used to diagnose non-Hodgkin’s lymphoma include:
*Physical examination. Your doctor may conduct a physical exam to determine the size and condition of your lymph nodes and to find out whether your liver and spleen are enlarged.
*Blood and urine tests. Swollen lymph nodes are common and most often signal that your body is fighting an infection. Blood and urine tests may help rule out an infection or other disease.
*Imaging tests. An X-ray or computerized tomography (CT) scan of your chest, neck, abdomen and pelvis may detect the presence and size of tumors. Magnetic resonance imaging (MRI) scans can help your doctor determine whether your brain and spinal cord are affected. Doctors also use positron emission tomography (PET) scanning to detect non-Hodgkin’s lymphoma. Imaging tests can help determine the stage of your lymphoma.
*Removing a sample of lymph node tissue for testing. Your doctor may recommend a biopsy procedure to sample or remove a lymph node for testing. Analyzing lymph node tissue in a laboratory may reveal whether you have non-Hodgkin’s lymphoma and, if so, which type. *Looking for cancer cells in your bone marrow. To find out whether the disease has spread, your doctor may request a biopsy of your bone marrow. This involves inserting a needle into your pelvic bone to obtain a sample of bone marrow.
Determining your type of non-Hodgkin’s lymphoma :-
Doctors classify non-Hodgkin’s lymphoma into many different types. Several methods for classifying types of non-Hodgkin’s lymphoma exist. Each method uses different combinations of factors, including:
*Whether your cancer involves B cells or T cells
*How the cells appear when examined using a microscope
*Specific genetic changes within the cancer cells
*Which antigens are present on the surface of the cancer cells
Doctors also assign a stage (I through IV) to the disease, based on the number of tumors and how widely the tumors have spread.
Treatment isn’t always necessary
If your lymphoma appears to be slow growing (indolent), a wait-and-see approach may be an option. Indolent lymphomas that don’t cause signs and symptoms may not require treatment for years.
Delaying treatment doesn’t mean you’ll be on your own. Your doctor will likely schedule regular checkups every few months to monitor your condition and ensure that your cancer isn’t advancing.
Treatment for lymphoma that causes signs and symptoms
If your non-Hodgkin’s lymphoma is aggressive or causes signs and symptoms, your doctor may recommend treatment.
Treatment planning takes into account the type of lymphoma, the stage of disease, whether it is likely to grow slowly or rapidly, and the general health and age of the patient. Common treatment options for several types are as follows:
Low-grade lymphomas include small lymphocytic, follicular small cleaved, and follicular mixed cell. For low-grade lymphomas, which usually grow very slowly and cause few symptoms, the doctor may wait until the disease shows signs of spreading before starting treatment.
Although low-grade lymphomas grow slowly and respond readily to chemotherapy, they almost invariably return and are generally regarded as incurable. The long-term outcome has not been favorably affected by the use of intermediate chemotherapy. Single agent or combination chemotherapy or radiation therapy may be required when the disease progresses or begins to cause symptoms.
Intermediate and High Grades
Intermediate grade includes follicular large cell, diffuse small cleaved, diffuse mixed cell, and diffuse large cell. The chance of recovery and choice of treatment depend on the stage of the cancer, age, and overall condition. Whatever the origin, the features that best predict the prognosis and guide decisions about therapy are the size, shape and pattern of the lymphocytes as seen microscopically.
Intermediate- and high-grade lymphomas are curable. Treatment for intermediate- or high-grade lymphomas usually involves chemotherapy, with or without radiation therapy. In addition, surgery may be needed to remove a large tumor.
Combination chemotherapy is almost always necessary for successful treatment. Chemotherapy alone, or abbreviated chemotherapy and radiation, cure 70 to 80 percent of patients with limited intermediate-grade lymphoma. Advanced disease can be eradicated in about 50 percent of patients.
Hodgkin’s Disease The usual treatment for most patients with early stage Hodgkin’s disease is high-energy radiation of the lymph nodes. Research has shown that radiation therapy to large areas at high doses (3,500 to 4,500 rads) is more effective in preventing relapse than radiation of the diseased nodes alone.
Combination chemotherapy also is effective in the treatment of early stage Hodgkin’s disease. In addition, chemotherapy is the treatment of choice for advanced (stages III and IV) Hodgkin’s disease and for patients who have relapsed after radiotherapy. Drugs and radiation are sometimes given together, mainly in treating patients with tumors in the chest or abdomen.
Coping and support:
A diagnosis of cancer can be overwhelming. With time you’ll find ways to cope with the distress and uncertainty of cancer. Until then, you may find it helps to: *Learn everything you want to know about your cancer. Find out everything you need to know about your cancer in order to help you make treatment decisions. Ask your doctor for the type and stage of your cancer, as well as your treatment options and their side effects. Ask your doctor where you can go for more information. Good places to start include the National Cancer Institute and the Leukemia & Lymphoma Society.
*Build a strong support system. Having a support system of close friends and family may help you cope. Though you may feel tempted to keep to yourself, be open with your loved ones. Friends will ask you if there’s anything they can do to help you. Think of requests ahead of time, such as preparing meals or just being there to talk.
*Connect with other cancer survivors. Sometimes you’ll feel as if your friends and family can’t understand what you’re going through. In these cases, other cancer survivors can offer support and practical information. You may also find you develop deep and lasting bonds with people who are going through the same things you are. Ask your doctor about support groups in your area. Or go online to Internet message boards, such as those offered by the Leukemia & Lymphoma Society.
*Set reasonable goals. Having goals helps you feel in control and can give you a sense of purpose. But don’t choose goals you can’t possibly reach. You may not be able to work a 40-hour week, for example, but you may be able to work at least part time. In fact, many people find that continuing to work can be helpful.
*Take time for yourself. Eating well, relaxing and getting enough rest can help combat the stress and fatigue of cancer. Also, plan ahead for when you may need to rest more or limit what you do.
*Stay active. Receiving a diagnosis of cancer doesn’t mean you have to stop doing the things you enjoy or normally do. For the most part, if you feel well enough to do something, go ahead and do it. Stay involved as much as you can. *Look for a connection to something beyond yourself. Having a strong faith or a sense of something greater than yourself may help you cope with having cancer. It may also help you maintain a more positive attitude as you face the challenge of cancer.
Disclaimer: This information is not meant to be a substitute for professional medical advise or help. It is always best to consult with a Physician about serious health concerns. This information is in no way intended to diagnose or prescribe remedies.This is purely for educational purpose.
Individuals who engage in compassion meditation may benefit by reductions in inflammatory and behavioral responses to psychological stress, a new Compassion study has found. CLICK & SEE THE PICTURES
“While much attention has been paid to meditation practices that emphasize calming the mind, improving focused attention or developing mindfulness, less is known about meditation practices designed to specifically foster compassion,” says Geshe Lobsang Tenzin Negi, PhD, who designed and taught the meditation program used in the study.
Negi is senior lecturer in the Department of Religion, the co-director of Emory Collaborative for Contemplative Studies and president and spiritual director of Drepung Loseling Monastery, Inc.
The study focused on the effect of compassion meditation on inflammatory, neuroendocrine and behavioral responses to psychosocial stress, and evaluated the degree to which engagement in meditation practice influenced stress reactivity.
“Our findings suggest that meditation practices designed to foster compassion may impact physiological pathways that are modulated by stress and are relevant to disease,” said Charles L. Raison, MD, clinical director of the Mind-Body Program, Emory University”s Department of Psychiatry and Behavioral Sciences, Emory School of Medicine, and a lead author on the study.
Sixty-one healthy college students between the ages of 17 and19 participated in the study. Half the participants were randomized to receive six weeks of compassion meditation training and half were randomized to a health discussion control group. Although secular in presentation, the compassion meditation program was based on a thousand-year-old Tibetan Buddhistmind-training practice called “lojong” in Tibetan.
A variety of student participation activities were employed such as mock debates and role-playing. Both groups were required to participate in 12 hours of classes across the study period. Meditators were provided with a meditation compact disc for practice at home. Homework for the control group was a weekly self-improvement paper.
After the study interventions were finished, the students participated in a laboratory stress test designed to investigate how the body”s inflammatory and neuroendocrine systems respond to psychosocial stress.
No differences were seen between students randomized to compassion meditation and the control group, but within the meditation group there was a strong relationship between the time spent practicing meditation and reductions in inflammation and emotional distress in response to the stressor.
Consistent with this, when the meditation group was divided into high and low practice groups, participants in the high practice group showed reductions in inflammation and distress in response to the stressor when compared to the low practice group and the control group.